Načítá se...
DPP4 Inhibition: Insights From the Bench and Recent Clinical Studies
PURPOSE OF REVIEW: Atherosclerosis is the leading cause of death globally. The pathophysiology of atherosclerosis is not fully understood. Recent studies suggest dipeptidyl peptidase-4 (DPP4), a regulator of inflammation and metabolism, may be involved in the development of atherosclerotic diseases....
Uloženo v:
| Vydáno v: | Curr Opin Lipidol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5147592/ https://ncbi.nlm.nih.gov/pubmed/27472408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOL.0000000000000340 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|